Haematological abnormalities in systemic lupus erythematosus

被引:2
|
作者
Aleem, Aamer [1 ]
Al Arfaj, Abdurahman Saud [2 ]
Khalil, Najma [2 ]
Alarfaj, Husain [2 ]
机构
[1] King Saud Univ, King Khalid Univ Hosp, Dept Med, Div Haematol Oncol, Riyadh, Saudi Arabia
[2] King Saud Univ, King Khalid Univ Hosp, Dept Med, Div Rheumatol, Riyadh, Saudi Arabia
来源
ACTA REUMATOLOGICA PORTUGUESA | 2014年 / 39卷 / 03期
关键词
Systemic lupus erythematosus; SLE; Haematological abnormalities; Follow-up; Organ involvement; AUTOIMMUNE HEMOLYTIC-ANEMIA; 3; ETHNIC-GROUPS; MULTIETHNIC COHORT; REVISED CRITERIA; APLASTIC-ANEMIA; RISK-FACTORS; THROMBOCYTOPENIA; PREVALENCE; SLE; AUTOANTIBODIES;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: This study was conducted to evaluate the frequency and pattern of haematological abnormalities (HA) in SLE patients at the time of diagnosis and last follow-up, and their relationship with organ involvement. Patients and methods: This retrospective study included patients who were diagnosed and treated for SLE from 1982 to 2008 at King Khalid University hospital, Riyadh. Demographic and haematological parameters at diagnosis and the last follow-up, disease manifestations, organ involvement and clinical haematological complications were recorded. Association of HA with organ involvement was explored by multivariate analysis. Results: A total of 624 patients (90.7% females, mean age 34.3 +/- 11.9 years) were studied. HA were present in 516 (82.7 %) patients at the time of diagnosis. Anaemia was the most frequent HA in 63.0% patients followed by lymphopenia in 40.3%, leukopenia in 30.0%, thrombocytopenia in 10.9% and autoimmune haemolytic anaemia (AIHA) in 4.6% patients. Deep vein thrombosis and pulmonary embolism were diagnosed in 7.4% and 2.6% patients respectively. After a mean follow-up of 9.3 +/- 5.3 years, 329/491 (67%) patients still had some HA present. Anaemia remained the most common abnormality (51.7% patients) followed by lymphopenia in 33.1%, and thrombocytopenia in 4.8% patients. Leukopenia was associated with oral ulcers (p=0.021) and alopecia (p=0.031), anaemia with renal disease (p=0.017), AIHA with neurological involvement (p=0.003), elevated IgG with malar rash (p=0.027), and low C3 with serositis (p=0.026). Conclusion: HA are very common at the time of diagnosis and during follow-up in SLE, and some of these abnormalities are associated with organ damage. This information may help in better management planning of SLE patients.
引用
收藏
页码:236 / 241
页数:6
相关论文
共 50 条
  • [31] Abnormalities of T cell signaling in systemic lupus erythematosus
    Vaishali R Moulton
    George C Tsokos
    Arthritis Research & Therapy, 13
  • [32] Features associated with hematologic abnormalities and their impact in patients with systemic lupus erythematosus: Data from a multiethnic Latin American cohort
    Gonzalez-Naranjo, Luis A.
    Martinez Betancur, Octavio
    Alarcon, Graciela S.
    Ugarte-Gil, Manuel F.
    Jaramillo-Arroyave, Daniel
    Wojdyla, Daniel
    Pons-Estel, Guillermo J.
    Rondon-Herrera, Federico
    Vasquez-Duque, Gloria M.
    Quintana-Lopez, Gerardo
    Da Silva, Nilzio A.
    Tavares Brenol, Joao C.
    Reyes-Llerena, Gil
    Pascual-Ramos, Virginia
    Amigo, Mary C.
    Massardo, Loreto
    Alfaro-Lozano, Jose
    Segami, Maria I.
    Esteva-Spinetti, Maria H.
    Iglesias-Gamarra, Antonio
    Pons-Estel, Bernardo A.
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2016, 45 (06) : 675 - 683
  • [33] Systemic Lupus Erythematosus A Complex, but Recognizable and Treatable Disease
    Smith, Benjamin J.
    PHYSICIAN ASSISTANT CLINICS, 2021, 6 (01) : 61 - 73
  • [34] Neuropsychiatric manifestations in a consecutive cohort of systemic lupus erythematosus; a single center study
    Abdul-Sattar, Amal Bakry
    Goda, Tarek
    Negm, Mohamed G.
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2013, 16 (06) : 715 - 723
  • [35] Non-thromboembolic risk in systemic lupus erythematosus associated with antiphospholipid syndrome
    Deak, M.
    Bocskai, M.
    Burcsar, S.
    Danyi, O.
    Fekete, Z.
    Kovacs, L.
    LUPUS, 2014, 23 (09) : 913 - 918
  • [36] Challenges in the care of patients with systemic lupus erythematosus and lupus nephritis in Latin America
    Elera-Fitzcarrald, Claudia
    Alarcon, Graciela S.
    Ugarte-Gil, Manuel F.
    EXPERT OPINION ON PHARMACOTHERAPY, 2025, 26 (04) : 447 - 455
  • [37] Systemic lupus erythematosus
    Kneitz, C
    Goebeler, M
    Tony, HP
    INTERNIST, 2003, 44 (12): : 1557 - 1573
  • [38] Systemic lupus erythematosus
    Hoi, Alberta
    Igel, Talia
    Mok, Chi Chiu
    Arnaud, Laurent
    LANCET, 2024, 403 (10441): : 2326 - 2338
  • [39] Systemic lupus erythematosus
    Aringer, M.
    Hiepe, F.
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2011, 70 (04): : 313 - 322
  • [40] Systemic lupus erythematosus
    Shaikh, Maliha F.
    Jordan, Natasha
    D'Cruz, David P.
    CLINICAL MEDICINE, 2017, 17 (01) : 78 - 83